In order to further the expansion of our brand product across the Asian region, we must first overcome the cost challenges of setting up new GMP standard production labs. We believe the solution to these expenditures lies with the automation of our product. By taking the human factor out of the equation, we can greatly reduce the risks of contamination, significantly save on manual labor costs, and dramatically shorten time on local production setup.
Our first goal is to design a semi-automated product, which will be operated by a trained technician through microscope and simple control interface. We believe production can be achieved within the next one to three years. The first year will involve taking designs, patents, and organizing the technical development team.
The next stage will involve the production and testing of a working semiautomated prototype. This would be a self-contained production lab that would be operated from the exterior by simple command buttons, and verified by a trained technician through microscope analysis.
The final stage will be the replication and larger scale production of the semi-automated lab. After the semi-automated machine is complete, our next ambition is to develop a fully automated product that can analyze the cells during each stage of processing using A.I. software.